AI-generated summary
The authors report a retrospective study of 192 men with androgenetic alopecia, comparing medication alone with medication plus six sessions of ablative fractional 2940-nm Er: YAG laser. At week 24, the combined treatment group showed better investigator and patient assessments and higher hair counts and diameters, with no severe adverse events reported.
- Participants
- 192
- Who or what was studied
- Men with androgenetic alopecia
- Wavelengths
- 2940 nm
- Limits stated in the abstract
- The study was retrospective, and the abstract does not describe a randomized design or control for group differences.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Androgenetic alopecia, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.